Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Food Nutr Bull ; 40(3): 393-408, 2019 09.
Article in English | MEDLINE | ID: mdl-31204503

ABSTRACT

BACKGROUND: Maternal spot feeding programs operational in southern Indian States are providing a package of nutrition services (food, micronutrient supplementation, deworming, gestation weight gain monitoring, and fortnightly nutrition health education) to pregnant women. These remain to be evaluated. OBJECTIVE: We evaluated the maternal spot feeding programs in 2 Southern Indian states. METHODS: Study design was cross-sectional entailing primary data collection (July to November 2016) on 360 pregnant and lactating women (of infants aged 0-6 months) per state and a review of the scheme's management information system (MIS) beneficiaries' records for the time period April 2014 to August 2017. To gain program functioning insights, open-ended interviews (n = 252) with state, district, and block program managers a state-level open space technology workshop was conducted. RESULTS: Average days of meal consumption ranged from 19 to 21 days per month; spot meal enhanced high dietary diversity (≥6 food groups; 57%-59%) and consumption of eggs and milk (74%-96%) among pregnant and lactating women. On-the-spot consumption of iron, folic acid, calcium, and deworming was 18%, 87%, and 56%, respectively; 94% attended at least 1 of the 2 nutrition monthly counseling sessions. Majority (68%) of the beneficiaries were motivated to enroll by self-help groups or family members, suggesting the crucial persuasive role of peers and family members. CONCLUSION: Maternal spot feeding schemes can potentially deliver nutrition interventions outlined in the World Health Organization antenatal care guidelines 2016 for a positive pregnancy outcome. Research on schemes' impact on birth outcomes, maternal depression, social norms, and its cost-effectiveness is needed.


Subject(s)
Food Assistance , Maternal Health Services , Maternal Nutritional Physiological Phenomena , Adult , Cross-Sectional Studies , Diet , Dietary Supplements , Female , Health Education , Humans , India , Infant , Infant, Newborn , Lactation , Micronutrients/administration & dosage , Nutrition Therapy , Nutritional Status , Pregnancy
2.
Indian Pediatr ; 56(1): 33-36, 2019 Jan 15.
Article in English | MEDLINE | ID: mdl-30806358

ABSTRACT

OBJECTIVE: To estimate incidence of side effects after weekly iron and folic acid supplementation (WIFS) in Delhi and Haryana. METHODS: In this cross-sectional school-based study, data were collected from 4,183 adolescents on WIFS consumption and side effects experienced first time of receipt of WIFS (week 1), and in last two consecutive weeks (week 2,3). Week 3 was 48 hours preceding the survey. RESULTS: WIFS consumption in week 1, 2 and 3 was 85%, 63% and 52%, respectively. Side effects reported were highest in first week (25%) and reduced to 7% (week 2) and 5% (week 3). Side effects most reported were abdominal pain (80%) and nausea (10%). Adolescents (45%) who faced a side-effect in week 1 did not consume WIFS in subsequent week. CONCLUSIONS: Incidence of side effects was low, but it affected compliance. Positive reinforcement to students who face side effects requires strengthening by teachers.


Subject(s)
Dietary Supplements/adverse effects , Folic Acid/adverse effects , Iron/adverse effects , Abdominal Pain/epidemiology , Abdominal Pain/etiology , Adolescent , Anemia, Iron-Deficiency/drug therapy , Cross-Sectional Studies , Dietary Supplements/statistics & numerical data , Female , Folic Acid/administration & dosage , Folic Acid/therapeutic use , Humans , Incidence , India/epidemiology , Iron/administration & dosage , Iron/therapeutic use , Male , Nausea/epidemiology , Nausea/etiology , Patient Compliance/statistics & numerical data , Students
4.
Indian J Community Med ; 41(2): 89-92, 2016.
Article in English | MEDLINE | ID: mdl-27051081

ABSTRACT

The universal megadose of vitamin A (MDVA) supplementation program was started in the year 1970. The program is presently in continuation for the prevention of nutritional blindness and possibly reduction in under-five mortality rate (U5MR). Presently, blindness due to vitamin A deficiency (VAD) has disappeared and the difference between U5MR and infant mortality rate (IMR) is less than 10 thus MDVA is unlikely to have any impact on mortality. The continuation of universal MDVA needs to be modified based on the current scientific evidence.

5.
J Trop Pediatr ; 61(2): 131-4, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25539777

ABSTRACT

There is limited data on proportion of Bitot's spots (BS), which could reappear after receiving mega dose of Vitamin A (MDVA), and their complete resolution. A prospective, community-based, cohort study with 12 months follow-up was conducted among children (1-5 years) with BS at a district from North India. On diagnosis, 200,000 IU of vitamin A was administered on the same day, then after 4 weeks and subsequently after 6 months. Out of 262 children with BS, 157 (59.9%, 95% CI: 54.1-65.9) children had shown resolution of BS after the MDVA supplementation. Out of 157 children, 97 (61.8%, 95% CI: 54.2-69.4) had reappearance of BS after complete resolution. Kaplan-Meir analysis found that median duration of reappearance of BS was 5 months (95% CI: 3.8-6.2) after their complete resolution. The reappearance of BS after administration of two MDVA within 12 months suggests that children with possibly adequate serum retinol level status may have reappearance of BS.


Subject(s)
Dietary Supplements , Eye Diseases/drug therapy , Vitamin A Deficiency/drug therapy , Vitamin A/administration & dosage , Vitamin A/therapeutic use , Child , Child, Preschool , Community-Based Participatory Research , Eye Diseases/etiology , Female , Follow-Up Studies , Humans , India/epidemiology , Infant , Male , Prospective Studies , Recurrence , Sex Factors , Treatment Outcome , Vitamin A/adverse effects , Vitamin A Deficiency/complications , Vitamin A Deficiency/epidemiology
8.
J Trace Elem Med Biol ; 26(2-3): 145-8, 2012 Jun.
Article in English | MEDLINE | ID: mdl-22683049

ABSTRACT

In severe iodine deficient areas, iodine deficiency has been documented to be an important etiological factor leading to poor fetal growth and development. Iodine is essential for physical growth and development of the central nervous system of the fetus. Iodine deficiency in pregnant mothers leads to increased incidence of infertility and abortions, perinatal mortality and infant child mortality. The clinical iodine supplementation trials have documented adverse health consequences due to iodine deficiency. Evidence from observational studies concludes that prevention of iodine deficiency can lead to reduction in infant mortality rate and facilitate to achieve millennium development goal-4.


Subject(s)
Iodine/deficiency , Congenital Hypothyroidism/mortality , Congenital Hypothyroidism/prevention & control , Dietary Supplements , Female , Humans , Infant Mortality , Infant, Newborn , Male , Pregnancy
SELECTION OF CITATIONS
SEARCH DETAIL